Jose C. R. Silva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jose C. R. Silva has a total of 353 co-authors. Here are the top co-authors by number of shared publications:
Aliaksandra Radzisheuskaya
Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK
12 shared publications- Austin Smith
Living Systems Institute and Department of Biosciences, University of Exeter, Exeter EX4 4QD, UK
10 shared publications - Thorold W. Theunissen
Department of Developmental Biology and Center of Regenerative Medicine, Washington University School of Medicine, St. Louis, MO, USA
10 shared publications - Jennifer Nichols
Institute of Genetics and Cancer, University of Edinburgh 1 MRC Human Genetics Unit Edinburgh EH4 2XU
8 shared publications Anouk L. van Oosten
Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Tennis Court Road, Cambridge CB2 1QR, UK; Department of Biochemistry, University of Cambridge, Tennis Court Road, Cambridge CB2 1GA, UK
7 shared publications- Huanhuan Li
Guangzhou National Laboratory, Guangzhou, China
6 shared publications
Latest Publications
- Open Access
- 20 October 2026
- Published by Springer Nature in Cellular and Molecular Life Sciences
TGF-β-induced PFKM downregulation drives metabolic reprogramming, EMT, and malignant progression in lung adenocarcinoma
- 20 October 2026
- Published by Springer Nature in Cellular and Molecular Life Sciences
Open AccessTGF-β-induced PFKM downregulation drives metabolic reprogramming, EMT, and malignant progression in lung adenocarcinoma
- Open Access
- 24 March 2026
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 41 (6) , 830-846
Human stem cell-based embryo models: innovation, ethics, and policy
The aim of this White Paper is to establish a foundational framework for research, technological development, and regulation in the emerging field of stem cell-based embryo models (SCBEMs). These models, generated from Pluripotent Stem Cells, are designed to recapitulate essential events in early stages of human development. They have the potential to illuminate the early stages of embryo development and implantation and hold promise as an avenue to address global health challenges, including infertility and pregnancy loss, congenital, neonatal and adult conditions, and the need for organ transplants. While SCBEMs are not a substitute for human embryos, their tractability for large-scale analysis and their abilities to model the earliest stages of embryonic development suggest that they will have a significant impact on reproductive biology and regenerative medicine. But SCBEMs do not just raise novel scientific questions; they pose ethical and legal questions that need to be addressed. The paper stems from a meeting of a core group of researchers that met at the Institut Pasteur in Paris in November 2024 and represents the views of an extended group that has worked to elaborate the documents as a consensus for the field. Here, we provide a framework to guide research in this new field. We do this by summarizing the state of the science, assessing current SCBEM research in relation to its primary future applications and addressing the need for continued ethical and regulatory oversight associated with this new field.
- 24 March 2026
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 41 (6) , 830-846
Open AccessHuman stem cell-based embryo models: innovation, ethics, and policy
The aim of this White Paper is to establish a foundational framework for research, technological development, and regulation in the emerging field of stem cell-based embryo models (SCBEMs). These models, generated from Pluripotent Stem Cells, are designed to recapitulate essential events in early stages of human development. They have the potential to illuminate the early stages of embryo development and implantation and hold promise as an avenue to address global health challenges, including infertility and pregnancy loss, congenital, neonatal and adult conditions, and the need for organ transplants. While SCBEMs are not a substitute for human embryos, their tractability for large-scale analysis and their abilities to model the earliest stages of embryonic development suggest that they will have a significant impact on reproductive biology and regenerative medicine. But SCBEMs do not just raise novel scientific questions; they pose ethical and legal questions that need to be addressed. The paper stems from a meeting of a core group of researchers that met at the Institut Pasteur in Paris in November 2024 and represents the views of an extended group that has worked to elaborate the documents as a consensus for the field. Here, we provide a framework to guide research in this new field. We do this by summarizing the state of the science, assessing current SCBEM research in relation to its primary future applications and addressing the need for continued ethical and regulatory oversight associated with this new field.
- Open Access
- 17 February 2026
- Published by SAGE Publications in Cell Transplantation
- Vol. 35
Engineering chromatin loops to control cell fate: LoopID reveals catalytic-independent functions of epigenetic regulators
Enhancer–promoter (E-P) interactions are central to cell-type-specific transcriptional programs, yet the molecular machinery that establishes and maintains these loops has remained poorly defined. A recent study by Jiang et al, published in Nature Genetics , presents a series of transformative discoveries that redefine our understanding of E-P interactions and their role in gene regulation and cell fate determination. The research introduces LoopID, a chromatin-interaction-based proteomic platform that, for the first time, enables systematic identification of protein components, termed the “looposome,” localized specifically at chromatin looping anchors. Using LoopID, they profile the “looposome” in mouse embryonic stem cells (ESCs) and uncover an unexpected, catalytic-independent role for the histone demethylase JMJD2 (KDM4) in organizing chromatin architecture through phase-separated condensates. Beyond mechanism, the study demonstrates that targeted assembly of JMJD2 condensates at defined genomic loci can engineer E-P interactions driving cellular reprogramming toward pluripotent and two-cell-like states. Together, these findings represent not only a major technical advance but also a conceptual leap—establish LoopID as a foundational technology for dissecting chromatin structure, introduce a new conceptual framework for epigenetic regulators as structural organizers, and provide a powerful strategy to manipulate cell fate by rewiring three-dimensional (3D) genome architecture.
- 17 February 2026
- Published by SAGE Publications in Cell Transplantation
- Vol. 35
Open AccessEngineering chromatin loops to control cell fate: LoopID reveals catalytic-independent functions of epigenetic regulators
Enhancer–promoter (E-P) interactions are central to cell-type-specific transcriptional programs, yet the molecular machinery that establishes and maintains these loops has remained poorly defined. A recent study by Jiang et al, published in Nature Genetics , presents a series of transformative discoveries that redefine our understanding of E-P interactions and their role in gene regulation and cell fate determination. The research introduces LoopID, a chromatin-interaction-based proteomic platform that, for the first time, enables systematic identification of protein components, termed the “looposome,” localized specifically at chromatin looping anchors. Using LoopID, they profile the “looposome” in mouse embryonic stem cells (ESCs) and uncover an unexpected, catalytic-independent role for the histone demethylase JMJD2 (KDM4) in organizing chromatin architecture through phase-separated condensates. Beyond mechanism, the study demonstrates that targeted assembly of JMJD2 condensates at defined genomic loci can engineer E-P interactions driving cellular reprogramming toward pluripotent and two-cell-like states. Together, these findings represent not only a major technical advance but also a conceptual leap—establish LoopID as a foundational technology for dissecting chromatin structure, introduce a new conceptual framework for epigenetic regulators as structural organizers, and provide a powerful strategy to manipulate cell fate by rewiring three-dimensional (3D) genome architecture.
- 1 February 2026
- Published by SAGE Publications in Cellular Reprogramming
- Vol. 28 (1) , 6-11
Reprogramming Stars #16: Reprogramming, from Cells to Embryos—An Interview with Dr. José Silva
- 1 February 2026
- Published by SAGE Publications in Cellular Reprogramming
- Vol. 28 (1) , 6-11
Reprogramming Stars #16: Reprogramming, from Cells to Embryos—An Interview with Dr. José Silva
- 17 September 2025
- Published by Elsevier in Cell Stem Cell
- Vol. 32 (10) , 1528-1544.e10
Signaling reprogramming via Stat3 activation unravels high-fidelity human post-implantation embryo modeling
- 17 September 2025
- Published by Elsevier in Cell Stem Cell
- Vol. 32 (10) , 1528-1544.e10
Signaling reprogramming via Stat3 activation unravels high-fidelity human post-implantation embryo modeling
- 14 August 2025
- Published by Springer Nature in Nature Cell Biology
Mouse trophectoderm stem cells generated with morula signalling inducers capture an early trophectoderm state
The first embryonic cell differentiation in mice segregates the trophectoderm and the inner cell mass. Successful derivation of mouse trophoblast stem cells (TSCs) and trophectoderm stem cells (TESCs) has greatly facilitated the understanding of trophoblast differentiation. However, our understanding of early trophectoderm differentiation remains incomplete. Here we report the establishment of a morula-derived trophectoderm stem cell (MTSC) line from 32-cell embryos that show enhanced and uniform trophoblast core gene expression. Importantly, distinct from TSCs or TESCs, MTSCs represent a much earlier trophectoderm state (E3.5) than that of TSCs (E5.5-6.5) and TESCs (E4.5-5.5). MTSCs can robustly integrate into all cell lineages of the placenta. Moreover, MTSCs can self-organize to form placenta organoids. When partially differentiated MTSCs aggregate with embryonic stem cells, they form blastoids that efficiently implant uteruses. Finally, MSTC medium can efficiently convert embryonic stem cells, TSCs and TESCs into MTSC-like cells. Thus, MTSCs capture an early blastocyst trophectoderm state and provide a research model for studying trophoblast development.
- 14 August 2025
- Published by Springer Nature in Nature Cell Biology
Mouse trophectoderm stem cells generated with morula signalling inducers capture an early trophectoderm state
The first embryonic cell differentiation in mice segregates the trophectoderm and the inner cell mass. Successful derivation of mouse trophoblast stem cells (TSCs) and trophectoderm stem cells (TESCs) has greatly facilitated the understanding of trophoblast differentiation. However, our understanding of early trophectoderm differentiation remains incomplete. Here we report the establishment of a morula-derived trophectoderm stem cell (MTSC) line from 32-cell embryos that show enhanced and uniform trophoblast core gene expression. Importantly, distinct from TSCs or TESCs, MTSCs represent a much earlier trophectoderm state (E3.5) than that of TSCs (E5.5-6.5) and TESCs (E4.5-5.5). MTSCs can robustly integrate into all cell lineages of the placenta. Moreover, MTSCs can self-organize to form placenta organoids. When partially differentiated MTSCs aggregate with embryonic stem cells, they form blastoids that efficiently implant uteruses. Finally, MSTC medium can efficiently convert embryonic stem cells, TSCs and TESCs into MTSC-like cells. Thus, MTSCs capture an early blastocyst trophectoderm state and provide a research model for studying trophoblast development.
- Open Access
Chemically induced cell plasticity enables the generation of high-fidelity embryo model
Summary: Embryo models open exciting opportunities for improving our understanding of development and advancing medicine. However, current models depend on intricate procedures and the integration of separately generated cell types. Here, we aimed to establish a chemical-only strategy to induce cellular plasticity and generate embryo founder-like cells. Within 60 hours, chemical-induced pluripotent stem cells activated early lineage specifiers, Cdx2 and Gata6 , while maintaining Oct4/ Pou5f1 expression. Following a second 36-hour chemical treatment, founder-like cells developed into all blastocyst fates and self-assembled into embryo-like structures. These progressed into high-fidelity late-streak gastrulation stages within 4.5 days, displaying primitive streak formation via epithelial-to-mesenchymal transition, along with germ-layer tissues, amnion, and ectoplacental cone. Fate trajectories and molecular signatures from founder-like cells to chemically-induced embryo model (ci-MO) were defined, revealing remarkable similarity up to Embryonic day (E) 7.5 embryo. Summarily, ci-MO offers a straightforward, rapid, small-molecule-only, and high-fidelity approach to study embryonic development and cell fate specification. Highlights: Generation of a direct, efficient, and sophisticated chemically induced embryo model (ci-MO) Two-pulse chemical induction reprograms ESCs into founder-like cells capable of developing all embryo fates Gastrulating ci-MOs display high morphological and molecular accuracy ci-MOs reconstruct embryo developmental trajectories
Open AccessChemically induced cell plasticity enables the generation of high-fidelity embryo model
Summary: Embryo models open exciting opportunities for improving our understanding of development and advancing medicine. However, current models depend on intricate procedures and the integration of separately generated cell types. Here, we aimed to establish a chemical-only strategy to induce cellular plasticity and generate embryo founder-like cells. Within 60 hours, chemical-induced pluripotent stem cells activated early lineage specifiers, Cdx2 and Gata6 , while maintaining Oct4/ Pou5f1 expression. Following a second 36-hour chemical treatment, founder-like cells developed into all blastocyst fates and self-assembled into embryo-like structures. These progressed into high-fidelity late-streak gastrulation stages within 4.5 days, displaying primitive streak formation via epithelial-to-mesenchymal transition, along with germ-layer tissues, amnion, and ectoplacental cone. Fate trajectories and molecular signatures from founder-like cells to chemically-induced embryo model (ci-MO) were defined, revealing remarkable similarity up to Embryonic day (E) 7.5 embryo. Summarily, ci-MO offers a straightforward, rapid, small-molecule-only, and high-fidelity approach to study embryonic development and cell fate specification. Highlights: Generation of a direct, efficient, and sophisticated chemically induced embryo model (ci-MO) Two-pulse chemical induction reprograms ESCs into founder-like cells capable of developing all embryo fates Gastrulating ci-MOs display high morphological and molecular accuracy ci-MOs reconstruct embryo developmental trajectories
- Open Access
- 29 March 2024
- Published by Elsevier in STAR Protocols
- Vol. 5 (2) , 102934
Protocol for generating mouse morula-like cells resembling 8- to 16-cell stage embryo cells
- 29 March 2024
- Published by Elsevier in STAR Protocols
- Vol. 5 (2) , 102934
Open AccessProtocol for generating mouse morula-like cells resembling 8- to 16-cell stage embryo cells
- Open Access
- 22 January 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-18
Self-renewing human naïve pluripotent stem cells dedifferentiate in 3D culture and form blastoids spontaneously
Human naïve pluripotent stem cells (hnPSCs) can generate integrated models of blastocysts termed blastoids upon switch to inductive medium. However, the underlying mechanisms remain obscure. Here we report that self-renewing hnPSCs spontaneously and efficiently give rise to blastoids upon three dimensional (3D) suspension culture. The spontaneous blastoids mimic early stage human blastocysts in terms of structure, size, and transcriptome characteristics and are capable of progressing to post-implantation stages. This property is conferred by the glycogen synthase kinase-3 (GSK3) signalling inhibitor IM-12 present in 5iLAF self-renewing medium. IM-12 upregulates oxidative phosphorylation-associated genes that underly the capacity of hnPSCs to generate blastoids spontaneously. Starting from day one of self-organization, hnPSCs at the boundary of all 3D aggregates dedifferentiate into E5 embryo-like intermediates. Intermediates co-express SOX2/OCT4 and GATA6 and by day 3 specify trophoblast fate, which coincides with cavity and blastoid formation. In summary, spontaneous blastoid formation results from 3D culture triggering dedifferentiation of hnPSCs into earlier embryo-like intermediates which are then competent to segregate blastocyst fates.
- 22 January 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-18
Open AccessSelf-renewing human naïve pluripotent stem cells dedifferentiate in 3D culture and form blastoids spontaneously
Human naïve pluripotent stem cells (hnPSCs) can generate integrated models of blastocysts termed blastoids upon switch to inductive medium. However, the underlying mechanisms remain obscure. Here we report that self-renewing hnPSCs spontaneously and efficiently give rise to blastoids upon three dimensional (3D) suspension culture. The spontaneous blastoids mimic early stage human blastocysts in terms of structure, size, and transcriptome characteristics and are capable of progressing to post-implantation stages. This property is conferred by the glycogen synthase kinase-3 (GSK3) signalling inhibitor IM-12 present in 5iLAF self-renewing medium. IM-12 upregulates oxidative phosphorylation-associated genes that underly the capacity of hnPSCs to generate blastoids spontaneously. Starting from day one of self-organization, hnPSCs at the boundary of all 3D aggregates dedifferentiate into E5 embryo-like intermediates. Intermediates co-express SOX2/OCT4 and GATA6 and by day 3 specify trophoblast fate, which coincides with cavity and blastoid formation. In summary, spontaneous blastoid formation results from 3D culture triggering dedifferentiation of hnPSCs into earlier embryo-like intermediates which are then competent to segregate blastocyst fates.